BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 37306818)

  • 1. iPSCs-Derived Neurons and Brain Organoids from Patients.
    Zhu W; Xu L; Li X; Hu H; Lou S; Liu Y
    Handb Exp Pharmacol; 2023; 281():59-81. PubMed ID: 37306818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system organoids for modeling neurodegenerative diseases.
    Hou PS; Kuo HC
    IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
    Lee CT; Bendriem RM; Wu WW; Shen RF
    J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders.
    Gabriel E; Gopalakrishnan J
    J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Evolving Role of Induced Pluripotent Stem Cells and Cerebral Organoids in Treating and Modeling Neurosurgical Diseases.
    Jovanovich N; Habib A; Kodavali C; Edwards L; Amankulor N; Zinn PO
    World Neurosurg; 2021 Nov; 155():171-179. PubMed ID: 34454068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
    Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
    Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generating Homogeneous Brain Organoids from Human iPSCs.
    Chen X; Shi Y
    Methods Mol Biol; 2024; 2794():157-167. PubMed ID: 38630227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of human airway-organoids from induced pluripotent stem cells (iPSCs).
    Wang R; McCauley KB; Kotton DN; Hawkins F
    Methods Cell Biol; 2020; 159():95-114. PubMed ID: 32586451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines.
    Barrett R; Ornelas L; Yeager N; Mandefro B; Sahabian A; Lenaeus L; Targan SR; Svendsen CN; Sareen D
    Stem Cells Transl Med; 2014 Dec; 3(12):1429-34. PubMed ID: 25298370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening Platforms for Genetic Epilepsies-Zebrafish, iPSC-Derived Neurons, and Organoids.
    Shcheglovitov A; Peterson RT
    Neurotherapeutics; 2021 Jul; 18(3):1478-1489. PubMed ID: 34595731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making Sense of Patient-Derived iPSCs, Transdifferentiated Neurons, Olfactory Neuronal Cells, and Cerebral Organoids as Models for Psychiatric Disorders.
    Unterholzner J; Millischer V; Wotawa C; Sawa A; Lanzenberger R
    Int J Neuropsychopharmacol; 2021 Oct; 24(10):759-775. PubMed ID: 34216465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of human vascularized brain organoids.
    Pham MT; Pollock KM; Rose MD; Cary WA; Stewart HR; Zhou P; Nolta JA; Waldau B
    Neuroreport; 2018 May; 29(7):588-593. PubMed ID: 29570159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy.
    Rispoli P; Scandiuzzi Piovesan T; Decorti G; Stocco G; Lucafò M
    WIREs Mech Dis; 2024; 16(1):e1630. PubMed ID: 37770042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Alzheimer's Disease Using Human Brain Organoids.
    Karmirian K; Holubiec M; Goto-Silva L; Fernandez Bessone I; Vitória G; Mello B; Alloatti M; Vanderborght B; Falzone TL; Rehen S
    Methods Mol Biol; 2023; 2561():135-158. PubMed ID: 36399268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids.
    Qu Y; Han B; Gao B; Bose S; Gong Y; Wawrowsky K; Giuliano AE; Sareen D; Cui X
    Stem Cell Reports; 2017 Feb; 8(2):205-215. PubMed ID: 28132888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and Culture of Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoid Cells.
    Yan Y; Arzua T; Logan S; Bai X
    Methods Mol Biol; 2022; 2454():483-494. PubMed ID: 33029748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome profiling of human pluripotent stem cell-derived cerebellar organoids reveals faster commitment under dynamic conditions.
    Silva TP; Sousa-Luís R; Fernandes TG; Bekman EP; Rodrigues CAV; Vaz SH; Moreira LM; Hashimura Y; Jung S; Lee B; Carmo-Fonseca M; Cabral JMS
    Biotechnol Bioeng; 2021 Jul; 118(7):2781-2803. PubMed ID: 33871054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion.
    Yuan T; Liao W; Feng NH; Lou YL; Niu X; Zhang AJ; Wang Y; Deng ZF
    Stem Cell Res Ther; 2013 Jun; 4(3):73. PubMed ID: 23769173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases.
    Bordoni M; Rey F; Fantini V; Pansarasa O; Di Giulio AM; Carelli S; Cereda C
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Complex Syngeneic Liver Organoids from Induced Pluripotent Stem Cells to Model Human Liver Pathophysiology.
    Raggi C; Selleri S; M'Callum MA; Paganelli M
    Curr Protoc; 2022 Mar; 2(3):e389. PubMed ID: 35263041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.